Hui AY - Search Results

1

Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis B.

Chan HL, Wong VW, Hui AY, Tsang SW, Chan JL, Chan HY, Wong GL, Sung JJ. Chan HL, et al. Among authors: hui ay. Antivir Ther. 2006;11(4):465-71. Antivir Ther. 2006. PMID: 16856620 Clinical Trial.

2

Use of hepatitis B virus DNA quantitation to predict hepatitis B e antigen reversion in cases of chronic hepatitis B.

Chan HL, Wong ML, Hui AY, Hung LC, Chan FK, Sung JJ. Chan HL, et al. Among authors: hui ay. J Clin Microbiol. 2003 Oct;41(10):4793-5. doi: 10.1128/JCM.41.10.4793-4795.2003. J Clin Microbiol. 2003. PMID: 14532223 Free PMC article.

3

Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment.

Chan HL, Wong ML, Hui AY, Chim AM, Tse AM, Hung LC, Chan FK, Sung JJ. Chan HL, et al. Among authors: hui ay. World J Gastroenterol. 2003 Dec;9(12):2695-7. doi: 10.3748/wjg.v9.i12.2695. World J Gastroenterol. 2003. PMID: 14669315 Free PMC article. Clinical Trial.

4

Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis.

Chan HL, Chui AK, Lau WY, Chan FK, Hui AY, Rao AR, Wong J, Lai EC, Sung JJ. Chan HL, et al. Among authors: hui ay. Clin Transplant. 2004 Jun;18(3):295-300. doi: 10.1111/j.1399-0012.2004.00163.x. Clin Transplant. 2004. PMID: 15142051

5

A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.

Chan HL, Leung NW, Hui AY, Wong VW, Liew CT, Chim AM, Chan FK, Hung LC, Lee YT, Tam JS, Lam CW, Sung JJ. Chan HL, et al. Among authors: hui ay. Ann Intern Med. 2005 Feb 15;142(4):240-50. doi: 10.7326/0003-4819-142-4-200502150-00006. Ann Intern Med. 2005. PMID: 15710957 Clinical Trial.

6

Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B.

Chan HL, Hui AY, Wong VW, Chim AM, Wong ML, Sung JJ. Chan HL, et al. Among authors: hui ay. Hepatology. 2005 Jun;41(6):1357-64. doi: 10.1002/hep.20695. Hepatology. 2005. PMID: 15880608 Clinical Trial.

7

Advances in chronic viral hepatitis.

Hui AY, Sung JJ. Hui AY, et al. Curr Opin Infect Dis. 2005 Oct;18(5):400-6. doi: 10.1097/01.qco.0000180163.84271.5e. Curr Opin Infect Dis. 2005. PMID: 16148526 Review.

8

Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B e antigen positive chronic hepatitis B.

Chan HL, Wong VW, Chim AM, Choi PC, Chan HY, Hui AY, Wong GL, Sung JJ. Chan HL, et al. Among authors: hui ay. Antivir Ther. 2007;12(5):815-23. Antivir Ther. 2007. PMID: 17713165 Clinical Trial.

9

Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.

Wong VW, Wong GL, Tsang SW, Hui AY, Chim AM, Yiu KK, Chan HY, Chan FK, Sung JJ, Chan HL. Wong VW, et al. Among authors: hui ay. Antivir Ther. 2008;13(4):571-9. Antivir Ther. 2008. PMID: 18672536 Clinical Trial.

10

Virodynamic predictors of response to pegylated interferon and lamivudine combination treatment of hepatitis B e antigen-positive chronic hepatitis B.

Mihm U, Chan HL, Zeuzem S, Chim AM, Hui AY, Wong VW, Sung JJ, Herrmann E. Mihm U, et al. Among authors: hui ay. Antivir Ther. 2008;13(8):1029-37. Antivir Ther. 2008. PMID: 19195328 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters